GE Healthcare showcased a broad range of technological evolutions in imaging that help healthcare providers understand the molecular root of diseases and explore new paths for detecting, treating and monitoring illnesses earlier at the 44th annual meeting of the American Society of Clinical Oncologists in Chicago, IL.

Visitors to the GE booth witnessed new advances in molecular imaging technologies such as the IN Cell Analyzer, Positron Emission Tomography/Volume Computer Assisted Reading (PET-VCAR), and Fastlab automated PET radiopharmacy. Next generation technologies were showcased in the innovative technology pavilion. Additionally, GE Healthcare demonstrated its breadth in Oncology, from treatment monitoring to productivity enhancing IT solutions.

"GE Healthcare's leadership in molecular imaging continues to attract partners from the pharmaceutical industry and academic centers of excellence worldwide," said Jean-Luc Vanderheyden, global molecular imaging leader at GE Healthcare. "ASCO provides a wonderful opportunity to reach out to health care providers to show all that we can offer and what we are working toward in the fields of oncology and molecular imaging."

IN Cell

Linking discovery and research with clinical oncology, GE Healthcare's IN Cell Analyzer System from its Life Science Division, represents a complete solution for high-content sub-cellular analysis. Used in research and drug discovery, the system performs assays directly inside cells and uses sophisticated image analysis techniques to give quantitative results for those assays for each individual cell. The power of the IN Cell Analyzer comes from using the high throughput it delivers to analyze thousands of cells under different conditions to generate statistically robust data.

PET-VCAR

PET-VCAR is a complement to GE's approach to personal patient management. The system helps optimize tumor management by enabling early quantification and evaluation of treatment effectiveness, a valuable tool for treatment planning. It features workflow enhancements for both single and multi-exam review, and includes exam-to-exam auto-registration; tumor segmentation and quantification; and multi-planar image review.

"PET-VCAR is designed to make PET/CT images even more useful to the clinician," said Henry Hummel, Global General Manager of GE Healthcare's PET/CT business. "It features an exclusive Interactive Data Analysis (IDA) that provides a 'report card' for clinicians to see, analyze, and compare tumors. That technology allows for better management of tumors over time; and it does so very efficiently."

More Industry Headlines